DNTH (Dianthus Pharma) Yalpi marja

Dianthus Corp (DNTH) kompaniyasining rasmiy ramzlari

Umumiy daromadning tushumdagi ulushi Dianthus Therapeutics (DNTH) kompaniyasining noyob patologiyalarni davolash uchun sug'urta to'lovlariga bog'liqligi bilan korrelyatsiyalanadi, bunda 85.70 joriy metrika darajasi vazifasini o'taydi. Biznes asosi immunologlar tomonidan olib boriladigan akademik R&D tadqiqotlariga tayanadi. Biroq, rivojlanishning ilk bosqichlarida mustaqil narx belgilash imkoniyatining yo'qligi kompaniyani zaif va butunlay tashqi ventura kapitali investitsiyalariga bog'liq qiladi.

DNTH - Dianthus Corp Yalpi foyda bo'yicha rentabellik 21.02.2024 - 20.11.2026 oraligʻida

Dianthus Corp (DNTH) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Kompaniyaning asosiy tahlili:DNTH - Dianthus Pharma
Dianthus Pharma tomonidan chiqariladigan mahsulotlar

Autoimmun patologiyalarni davolash uchun innovatsion antitanachalar ishlab chiqayotgan Dianthus Therapeutics (DNTH) hozirda patent ustunligiga erishish uchun shiddatli raqobat bosqichida. Valo martja ulushini tahlil qilish orqali investor bevosita ishlab chiqarish xarajatlarini qoplash samaradorligini baholaydi, bu esa aktivning kapital intensivligini va biznesning fundamental barqarorligini belgilaydi. Ushbu metrikaning barqaror tendentsiyasi kompaniyaning sotilgan tovarlar tannarxining kritik darajada oshmagan holda ishlanmalarni kengaytirish qobiliyatini tasdiqlaydi.

Muhim raqobatchilar

argenx - Yalpi foyda normasi|Yalpi rentabellik biontech.de|ABIVAX (ABVX) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja ADMA|Yalpi foyda koeffitsiyenti PTGX|Yalpi rentabellik Immunovant Corp IMVT|Yalpi marja Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Yalpi foyda bo'yicha rentabellik|Aurinia Pharmaceuticals Inc. (AUPH) - Yalpi marja|Yalpi foyda bo'yicha rentabellik BCRX|Yalpi foyda marjasi Vera Therapeutics Inc VERA|Yalpi rentabellik Pharvaris Pharma (PHVS)|Yalpi marja AbCellera Corp (ABCL)|Yalpi marja TRML (Tourmaline Bio Inc)|Yalpi foyda bo'yicha sotuv rentabelligi precigen.com (PGEN)|PHAR - Yalpi rentabellik|Yalpi foyda normasi NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Yalpi foyda bo'yicha rentabellik|Zenas Corp (ZBIO) - Yalpi marja|Yalpi foyda bo'yicha rentabellik IMNM|GOSS: Yalpi foyda normasi|Yalpi rentabellik KalVista Pharma (KALV)|SEPN - Yalpi foyda marjasi|Yalpi marja PVLA (pieris.com)|Yalpi marja Savara Pharma SVRA|RIGL: Yalpi foyda bo'yicha rentabellik|ANAB - Yalpi marja|ATXS: Yalpi marja|ENGN - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi foyda bo'yicha rentabellik RAPT|JBIO (Aerovate Therapeutics Inc) - Yalpi foyda koeffitsiyenti|Yalpi marja ACRS|Yalpi foyda bo'yicha rentabellik kyvernatx.com KYTX|Yalpi marja TLSA (Tiziana Life Sciences, Ltd.)|Yalpi marja Cabaletta Bio CABA|VTYX: Yalpi foyda bo'yicha rentabellik|Theratechnologies Inc. (THTX) - Yalpi foyda bo'yicha rentabellik|AVTX: Yalpi marja|ELDN - Yalpi foyda bo'yicha sotuv rentabelligi|AGEN (Agenus, Inc) - Yalpi marja|Yalpi marja Climb Bio, Inc.|Yalpi rentabellik Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Yalpi foyda normasi|Yalpi marja ADAG (Adagene Inc)|IMA - Yalpi foyda bo'yicha rentabellik|STTK - Yalpi rentabellik|EQ (equilliumbio.com) - Sotuvning yalpi rentabelligi|CNTB: Yalpi marja|Immunic Inc (IMUX) - Yalpi marja|ATRA (Atara Biotherapeutics Inc) - Yalpi marja|Sotuvning yalpi rentabelligi IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Yalpi foyda normasi|Adicet Bio, Inc. - Sotuvning yalpi rentabelligi|Celularity Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja INmune Bio Corporation INMB|Barinthus Biotherapeutics - Yalpi marja|Kezar Life Sciences, Inc. (KZR) - Yalpi foyda bo'yicha rentabellik|SAB Biotherapeutics Inc. (SABS) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Akari Therapeutics plc|Yalpi rentabellik enlivex.com|q32bio.com (QTTB) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja GOVX|Edesa Biotech, Inc. - Sotuvning yalpi rentabelligi|iBio Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja Carisma Therapeutics CARM|XTLB - Yalpi rentabellik|BOLT (boltbio.com) - Sotuvning yalpi rentabelligi|HCWB: Yalpi marja|Aptevo (APVO) - Yalpi marja|Yalpi rentabellik AIM ImmunoTech|Yalpi foyda bo'yicha rentabellik Aditxt (ADTX)|Yalpi foyda bo'yicha rentabellik GRI (GRI Bio Corporation)|XORTX - Sotuvning yalpi rentabelligi|Yalpi marja HIND (Vyome Holdings Inc.)|Yalpi foyda normasi REVB|Indaptus - Yalpi marja|SCNI (Scinai Immunotherapeutics Ltd.) - Sotuvning yalpi rentabelligi|CALI: Yalpi marja|Affimed NV - Yalpi foyda normasi|Yalpi rentabellik Allakos Inc.|Yalpi marja HOOKIPA Pharma|Yalpi rentabellik IGM Biosciences, Inc. (IGMS)|ITOS - Yalpi foyda marjasi|Yalpi marja OCEA (Ocean Bio)|Yalpi foyda normasi TCBP|THRD - Yalpi rentabellik